GlassScriptPhysician profile
Teck K Khoo
NPI 1487624037
$6,214.95
in general payments reported to CMS, 2019-2025
17 companies · $450 in 2025
The $450 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,958 · 2020: $602 · 2021: $38.90 · 2022: $44.37 · 2023: $108 · 2024: $14.09 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $300 · Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $300.00 |
| Food and Beverage | $271.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,096.00 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $2,179.89 | 2019-2020 | |
| Chiesi USA, INC. | $300.00 | 2025 | Mycapssa |
| Amgen INC. | $149.86 | 2025 | Tepezza |
| Horizon Therapeutics Plc | $126.67 | 2019-2023 | Tepezza |
| Abbott Laboratories | $66.51 | 2019-2021 | |
| Novo Nordisk INC | $61.38 | 2019-2020 | |
| Medtronic, INC. | $44.37 | 2022 | |
| Antares Pharma, INC. | $38.47 | 2019 | |
| Tandem Diabetes Care, INC. | $29.61 | 2020 | |
| Nevro Corp. | $26.10 | 2021 | |
| Insulet Corporation | $21.84 | 2019 | |
| Abbvie INC. | $18.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.54 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.62 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $13.00 | 2019 | |
| Shire North American Group INC | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teck Khoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.